Picture of YARROW BIOSCIENCE logo

YARW — YARROW BIOSCIENCE News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: VYNE Therapeutics FY Revenue USD 501 Thousand

Mar 06 (Reuters) - VYNE Therapeutics FY net income USD -39.834 million.

FY basic EPS USD -0.93

FY EPS from cont ops USD -0.93

Recent news on YARROW BIOSCIENCE

See all news